Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$5,999,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$5,999,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BROADWOOD PARTNERS, L.P. +$6.0M 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-03-15 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +87,500 87,500
2022-03-15 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +87,500 87,500
2022-03-15 Levine Mitchell S Chief Financial Officer Purchase +25,000 $1.17 $29K 87,080
2021-04-28 Levine Mitchell S Chief Financial Officer Exercise or conversion +20,000 66,700
2021-04-28 Levine Mitchell S Chief Financial Officer Shares withheld for taxes −4,620 62,080
2021-04-28 Levine Mitchell S Chief Financial Officer Exercise or conversion · Restricted Stock Units −20,000 0
2021-02-25 Levine Mitchell S Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +255,000 $5.34 $1.4M 255,000
2020-12-11 Levine Mitchell S CFO Grant or award +10,121 46,700
2020-09-12 Levine Mitchell S CFO Purchase +10,000 $2.01 $20K 13,495
2020-08-03 Levine Mitchell S Chief Financial Officer Purchase +10,000 $1.32 $13K 36,579
2020-04-28 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units +20,000 20,000
2020-04-28 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units −20,000 20,000
2020-03-14 Levine Mitchell S Chief Financial Officer Exercise or conversion +20,000 33,495
2020-03-14 Levine Mitchell S Chief Financial Officer Shares withheld for taxes −6,916 26,579
2020-03-14 Levine Mitchell S Chief Financial Officer Exercise or conversion · Restricted Stock Units −20,000 0
2020-02-10 Levine Mitchell S Chief Financial Officer Grant or award · Option to purchase common stock +204,000 204,000
2019-09-12 Levine Mitchell S CFO Purchase +10,000 $2.01 $20K 13,495
2019-09-12 Levine Mitchell S Chief Financial Officer Purchase +10,000 $2.01 $20K 10,000
2019-03-14 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +245,000 245,000
2019-03-14 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units +20,000 20,000

Page 1 of 2 · 26 trades